Company news

Medmira Inc. (TSXV:MIR) news

Medmira Inc. news releases on 6ix. Latest, Feb 9, 2022: MedMira Receives CE Marking for its REVEALCOVID-19 PLUS Total Antibody Test

View Medmira Inc. →

Press releases — page 2

MedMira Receives CE Marking for its REVEALCOVID-19 PLUS Total Antibody Test

February 9, 2022

MedMira Receives CE Marking for its REVEALCOVID-19® PLUS Total Antibody Test

February 7, 2022

MedMira Provides a Pre-Annual General Meeting Update

February 4, 2022

MedMira Reports First Quarter Results FY2022

December 29, 2021

MedMira Announces VYRA™ CoV2Flu and Additional Regulatory Opportunities

December 20, 2021

IIROC Trading Resumption - MIR

May 27, 2020

IIROC Trading Halt - MIR

May 27, 2020

IIROC Trading Resumption - MIR;SSH.P

October 5, 2018

IIROC Trade Halt - Medmira Inc.

October 19, 2015

MedMira Opens US Subsidiary in Atlanta, GA

July 20, 2015

MedMira Reports Third Quarter Results

May 29, 2015

MedMira Submits Reveal G4 Whole Blood Rapid HIV Test For U.S. FDA Approval

April 20, 2015

MedMira Directors Granted Stock Options

April 13, 2015

MedMira Closes Equity Investment with OnSite Lab

March 27, 2015

MedMira Expands U.S. Growth Plan with New Equity Investment from OnSite Lab

March 25, 2015

MedMira Reports Second Quarter Results

March 20, 2015

MedMira Board of Directors Re-elected at Annual Shareholders Meeting

February 5, 2015

Two of MedMira's Multiplo(TM) Tests Procured for UNAIDS Program in Central Asia

January 28, 2015

MedMira Reports First Quarter Results

December 24, 2014

MedMira Reports 2014 Fourth Quarter and Year End Financial Results

November 28, 2014

MedMira Names Robyn Cook as Chief Corporate Officer

November 4, 2014

MedMira Scores New Contract to Develop Rapid Colon Cancer Test with Beacon Biomedical

October 8, 2014

MedMira Closes New Equity Investment to Expand Sales & Marketing in Key Markets

October 2, 2014

MedMira Expands Multiplo Product Range with Three New Rapid Vertical Flow Tests

July 16, 2014

Top Ranking MedMira Rapid HIV Test Garners Additional Tender Sales in China

July 14, 2014

MedMira Announces Chief Financial Officer Transition

July 11, 2014

MedMira Showcases its Multiplo Line of Rapid Tests at the 2014 STD Prevention Conference

June 10, 2014

MedMira Announces Changes to Board of Directors

May 6, 2014

MedMira Brings First Comprehensive Point-of-Care Rapid HIV Test to Mexico

March 19, 2014

MedMira to Submit Cutting-Edge Rapid HIV Test for WHO Prequalification

March 18, 2014

MedMira Receives Approval To Market Reveal® Rapid HIV Test With New Features in Europe

March 13, 2014

MedMira's New Miriad(TM) RVF Toolkit Offers Researchers Speedier Test Results

March 10, 2014

MedMira Grants Stock Options to Officers and Directors

March 3, 2014

MedMira Partners with Colombian National Navy to Screen Pregnant Women for Syphilis and HIV as Part of Expansion in Latin America

February 5, 2014

MedMira Board of Directors Elected at Annual Shareholders Meeting

January 24, 2014

MedMira Embarks on Major U.S. Expansion with VWR International, LLC Agreement

January 13, 2014

Jelle Kuypers Appointed Chief Financial Officer of MedMira

December 9, 2013

MedMira Announces CFO Departure

December 2, 2013

MedMira Reports 2013 Fourth Quarter and Year End Financial Results

November 27, 2013

MedMira to Collaborate with the National Research Council of Canada on Advanced Sensitivity and Automated Detection in Future Rapid Diagnostics

November 12, 2013

MedMira Expands Applications for New Products with Additional US Army Funding

October 21, 2013

MedMira Sharpens Sales and Business Development Focus with Key Hires

September 26, 2013

New OnSite Lab Investment Enables MedMira to Expand Sales Programs and Manufacturing Capacity Ahead of Planned Product Launches

September 20, 2013

MedMira CEO Awarded Honorary Doctor of Science by Acadia University

August 21, 2013

MedMira Fueled with Capital Injection to Advance US Market Opportunities

June 5, 2013

MedMira Strengthens Sales Distribution Channel in the US

April 16, 2013

MedMira Attends FDA Public Workshop as Interest in its Multiplex Rapid Tests Continues to Increase

April 11, 2013

MedMira Submits Syphilis/HIV Combination Test for WHO Approval Upon Invitation to Prequalification Program

March 11, 2013

MedMira Reports First Quarter Results with an Increase in Revenues Over Last Year

December 27, 2012

MedMira Files Pre-IDE with FDA for New Rapid HIV Test to Meet Demand for Increased Routine Screening in the US

November 30, 2012

← Newer · Older →